Monoclonal Anti-Nipah Post Fusion glycoprotein Antibody, Human IgG1 (2B2) (MALS verified)
Produktmerkmale
Monoclonal Anti-Nipah Post Fusion glycoprotein Antibody, Human IgG1 (2B2) is a chimeric monoclonal antibody recombinantly expressed from HEK293, which combines the variable region of a mouse monoclonal antibody with Human constant domain.
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Handhabung
Please avoid repeated freeze-thaw cycles.
Lagerung
-20 °C,-80 °C
Informationen zur Lagerung
For long term storage, the product should be stored at lyophilized state at -20°C or lower. This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
Target
Nipah Virus Post-Fusion Glycoprotein (NIV pF)
Andere Bezeichnung
Nipah Virus Post-Fusion Glycoprotein
Hintergrund
Hendra virus (HeV) and Nipah virus (NiV) are henipaviruses discovered in the mid-to late 1990s that possess a broad host tropism and are known to cause severe and often fatal disease in both humans and animals. HeV and NiV infect host cells through the co